Correlation Between Exagen and Olink Holding
Can any of the company-specific risk be diversified away by investing in both Exagen and Olink Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exagen and Olink Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Exagen Inc and Olink Holding AB, you can compare the effects of market volatilities on Exagen and Olink Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exagen with a short position of Olink Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exagen and Olink Holding.
Diversification Opportunities for Exagen and Olink Holding
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Exagen and Olink is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Exagen Inc and Olink Holding AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Olink Holding AB and Exagen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exagen Inc are associated (or correlated) with Olink Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Olink Holding AB has no effect on the direction of Exagen i.e., Exagen and Olink Holding go up and down completely randomly.
Pair Corralation between Exagen and Olink Holding
If you would invest 428.00 in Exagen Inc on December 28, 2024 and sell it today you would lose (4.00) from holding Exagen Inc or give up 0.93% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Exagen Inc vs. Olink Holding AB
Performance |
Timeline |
Exagen Inc |
Olink Holding AB |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Exagen and Olink Holding Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Exagen and Olink Holding
The main advantage of trading using opposite Exagen and Olink Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exagen position performs unexpectedly, Olink Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Olink Holding will offset losses from the drop in Olink Holding's long position.Exagen vs. Fonar | Exagen vs. Burning Rock Biotech | Exagen vs. Sera Prognostics | Exagen vs. Castle Biosciences |
Olink Holding vs. Fonar | Olink Holding vs. Burning Rock Biotech | Olink Holding vs. Sera Prognostics | Olink Holding vs. DarioHealth Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |